nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—CYP3A4—type 2 diabetes mellitus	0.237	1	CbGaD
Indacaterol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0781	0.153	CbGbCtD
Indacaterol—UGT1A1—Losartan—type 2 diabetes mellitus	0.0726	0.142	CbGbCtD
Indacaterol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0477	0.0934	CbGbCtD
Indacaterol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0425	0.0833	CbGbCtD
Indacaterol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0307	0.0602	CbGbCtD
Indacaterol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0286	0.056	CbGbCtD
Indacaterol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0255	0.0499	CbGbCtD
Indacaterol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0233	0.0456	CbGbCtD
Indacaterol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0211	0.0414	CbGbCtD
Indacaterol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0204	0.0399	CbGbCtD
Indacaterol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0184	0.0361	CbGbCtD
Indacaterol—ABCB1—Glyburide—type 2 diabetes mellitus	0.0157	0.0308	CbGbCtD
Indacaterol—ABCB1—Losartan—type 2 diabetes mellitus	0.0144	0.0282	CbGbCtD
Indacaterol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.014	0.0273	CbGbCtD
Indacaterol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0134	0.0262	CbGbCtD
Indacaterol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0134	0.0262	CbGbCtD
Indacaterol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0127	0.0248	CbGbCtD
Indacaterol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00943	0.0185	CbGbCtD
Indacaterol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00862	0.0169	CbGbCtD
Indacaterol—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.00034	0.00194	CcSEcCtD
Indacaterol—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00034	0.00194	CcSEcCtD
Indacaterol—Infection—Bromocriptine—type 2 diabetes mellitus	0.000339	0.00193	CcSEcCtD
Indacaterol—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000337	0.00192	CcSEcCtD
Indacaterol—Nausea—Nateglinide—type 2 diabetes mellitus	0.000336	0.00192	CcSEcCtD
Indacaterol—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000336	0.00192	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000335	0.00191	CcSEcCtD
Indacaterol—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000335	0.00191	CcSEcCtD
Indacaterol—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000333	0.0019	CcSEcCtD
Indacaterol—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000331	0.00189	CcSEcCtD
Indacaterol—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00033	0.00188	CcSEcCtD
Indacaterol—Pneumonia—Losartan—type 2 diabetes mellitus	0.000328	0.00187	CcSEcCtD
Indacaterol—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000328	0.00187	CcSEcCtD
Indacaterol—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000327	0.00187	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000327	0.00186	CcSEcCtD
Indacaterol—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000326	0.00186	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00186	CcSEcCtD
Indacaterol—Myalgia—Glyburide—type 2 diabetes mellitus	0.000325	0.00186	CcSEcCtD
Indacaterol—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000325	0.00185	CcSEcCtD
Indacaterol—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000324	0.00185	CcSEcCtD
Indacaterol—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000323	0.00184	CcSEcCtD
Indacaterol—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000323	0.00184	CcSEcCtD
Indacaterol—Tremor—Gliclazide—type 2 diabetes mellitus	0.000322	0.00183	CcSEcCtD
Indacaterol—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000317	0.00181	CcSEcCtD
Indacaterol—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000315	0.0018	CcSEcCtD
Indacaterol—Asthma—Ramipril—type 2 diabetes mellitus	0.000314	0.00179	CcSEcCtD
Indacaterol—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000312	0.00178	CcSEcCtD
Indacaterol—Rash—Repaglinide—type 2 diabetes mellitus	0.000309	0.00176	CcSEcCtD
Indacaterol—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000309	0.00176	CcSEcCtD
Indacaterol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000309	0.00176	CcSEcCtD
Indacaterol—Headache—Repaglinide—type 2 diabetes mellitus	0.000307	0.00175	CcSEcCtD
Indacaterol—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000307	0.00175	CcSEcCtD
Indacaterol—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Sinusitis—Losartan—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000306	0.00175	CcSEcCtD
Indacaterol—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000306	0.00174	CcSEcCtD
Indacaterol—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000304	0.00174	CcSEcCtD
Indacaterol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000303	0.00173	CcSEcCtD
Indacaterol—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000303	0.00173	CcSEcCtD
Indacaterol—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.0003	0.00171	CcSEcCtD
Indacaterol—Cough—Gliclazide—type 2 diabetes mellitus	0.000299	0.00171	CcSEcCtD
Indacaterol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000299	0.0017	CcSEcCtD
Indacaterol—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000298	0.0017	CcSEcCtD
Indacaterol—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000297	0.0017	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000295	0.00168	CcSEcCtD
Indacaterol—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000292	0.00167	CcSEcCtD
Indacaterol—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000292	0.00167	CcSEcCtD
Indacaterol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000292	0.00167	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000292	0.00166	CcSEcCtD
Indacaterol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000292	0.00166	CcSEcCtD
Indacaterol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000291	0.00166	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00029	0.00166	CcSEcCtD
Indacaterol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00029	0.00165	CcSEcCtD
Indacaterol—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000289	0.00165	CcSEcCtD
Indacaterol—Malnutrition—Metformin—type 2 diabetes mellitus	0.000287	0.00164	CcSEcCtD
Indacaterol—Pruritus—Glipizide—type 2 diabetes mellitus	0.000287	0.00164	CcSEcCtD
Indacaterol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000286	0.00163	CcSEcCtD
Indacaterol—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000286	0.00163	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000284	0.00162	CcSEcCtD
Indacaterol—Vertigo—Valsartan—type 2 diabetes mellitus	0.000283	0.00162	CcSEcCtD
Indacaterol—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000281	0.0016	CcSEcCtD
Indacaterol—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000281	0.0016	CcSEcCtD
Indacaterol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00028	0.0016	CcSEcCtD
Indacaterol—Vertigo—Orlistat—type 2 diabetes mellitus	0.00028	0.0016	CcSEcCtD
Indacaterol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000279	0.00159	CcSEcCtD
Indacaterol—Palpitations—Valsartan—type 2 diabetes mellitus	0.000279	0.00159	CcSEcCtD
Indacaterol—Infection—Gliclazide—type 2 diabetes mellitus	0.000278	0.00159	CcSEcCtD
Indacaterol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000278	0.00159	CcSEcCtD
Indacaterol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000278	0.00159	CcSEcCtD
Indacaterol—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000276	0.00158	CcSEcCtD
Indacaterol—Palpitations—Orlistat—type 2 diabetes mellitus	0.000275	0.00157	CcSEcCtD
Indacaterol—Cough—Valsartan—type 2 diabetes mellitus	0.000275	0.00157	CcSEcCtD
Indacaterol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000275	0.00157	CcSEcCtD
Indacaterol—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000275	0.00157	CcSEcCtD
Indacaterol—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000273	0.00156	CcSEcCtD
Indacaterol—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000272	0.00155	CcSEcCtD
Indacaterol—Cough—Orlistat—type 2 diabetes mellitus	0.000272	0.00155	CcSEcCtD
Indacaterol—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000271	0.00155	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000269	0.00154	CcSEcCtD
Indacaterol—Tremor—Metformin—type 2 diabetes mellitus	0.000269	0.00153	CcSEcCtD
Indacaterol—Chest pain—Valsartan—type 2 diabetes mellitus	0.000268	0.00153	CcSEcCtD
Indacaterol—Myalgia—Valsartan—type 2 diabetes mellitus	0.000268	0.00153	CcSEcCtD
Indacaterol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000268	0.00153	CcSEcCtD
Indacaterol—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000268	0.00153	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000267	0.00152	CcSEcCtD
Indacaterol—Myalgia—Orlistat—type 2 diabetes mellitus	0.000265	0.00151	CcSEcCtD
Indacaterol—Chest pain—Orlistat—type 2 diabetes mellitus	0.000265	0.00151	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000263	0.0015	CcSEcCtD
Indacaterol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000263	0.0015	CcSEcCtD
Indacaterol—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000263	0.0015	CcSEcCtD
Indacaterol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000261	0.00149	CcSEcCtD
Indacaterol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000259	0.00148	CcSEcCtD
Indacaterol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000257	0.00147	CcSEcCtD
Indacaterol—Infection—Valsartan—type 2 diabetes mellitus	0.000256	0.00146	CcSEcCtD
Indacaterol—Rash—Glipizide—type 2 diabetes mellitus	0.000256	0.00146	CcSEcCtD
Indacaterol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000255	0.00146	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000255	0.00146	CcSEcCtD
Indacaterol—Headache—Glipizide—type 2 diabetes mellitus	0.000254	0.00145	CcSEcCtD
Indacaterol—Tremor—Irbesartan—type 2 diabetes mellitus	0.000254	0.00145	CcSEcCtD
Indacaterol—Palpitations—Metformin—type 2 diabetes mellitus	0.000254	0.00145	CcSEcCtD
Indacaterol—Infection—Orlistat—type 2 diabetes mellitus	0.000253	0.00144	CcSEcCtD
Indacaterol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000252	0.00144	CcSEcCtD
Indacaterol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000252	0.00144	CcSEcCtD
Indacaterol—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00025	0.00143	CcSEcCtD
Indacaterol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00025	0.00143	CcSEcCtD
Indacaterol—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00025	0.00143	CcSEcCtD
Indacaterol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00025	0.00142	CcSEcCtD
Indacaterol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000249	0.00142	CcSEcCtD
Indacaterol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000249	0.00142	CcSEcCtD
Indacaterol—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000247	0.00141	CcSEcCtD
Indacaterol—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000247	0.00141	CcSEcCtD
Indacaterol—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000247	0.00141	CcSEcCtD
Indacaterol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000245	0.0014	CcSEcCtD
Indacaterol—Myalgia—Metformin—type 2 diabetes mellitus	0.000244	0.00139	CcSEcCtD
Indacaterol—Chest pain—Metformin—type 2 diabetes mellitus	0.000244	0.00139	CcSEcCtD
Indacaterol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000243	0.00139	CcSEcCtD
Indacaterol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000243	0.00139	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000243	0.00139	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000242	0.00138	CcSEcCtD
Indacaterol—Nausea—Glipizide—type 2 diabetes mellitus	0.000241	0.00137	CcSEcCtD
Indacaterol—Tremor—Losartan—type 2 diabetes mellitus	0.000239	0.00136	CcSEcCtD
Indacaterol—Rash—Glimepiride—type 2 diabetes mellitus	0.000238	0.00136	CcSEcCtD
Indacaterol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000238	0.00136	CcSEcCtD
Indacaterol—Rash—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00136	CcSEcCtD
Indacaterol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00136	CcSEcCtD
Indacaterol—Headache—Glimepiride—type 2 diabetes mellitus	0.000237	0.00135	CcSEcCtD
Indacaterol—Cough—Irbesartan—type 2 diabetes mellitus	0.000236	0.00135	CcSEcCtD
Indacaterol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00135	CcSEcCtD
Indacaterol—Anaemia—Losartan—type 2 diabetes mellitus	0.000236	0.00134	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000234	0.00134	CcSEcCtD
Indacaterol—Infection—Metformin—type 2 diabetes mellitus	0.000233	0.00133	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000232	0.00132	CcSEcCtD
Indacaterol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000231	0.00132	CcSEcCtD
Indacaterol—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000231	0.00132	CcSEcCtD
Indacaterol—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000231	0.00132	CcSEcCtD
Indacaterol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00023	0.00131	CcSEcCtD
Indacaterol—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00023	0.00131	CcSEcCtD
Indacaterol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000229	0.00131	CcSEcCtD
Indacaterol—Vertigo—Losartan—type 2 diabetes mellitus	0.000229	0.00131	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000229	0.00131	CcSEcCtD
Indacaterol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000228	0.0013	CcSEcCtD
Indacaterol—Skin disorder—Metformin—type 2 diabetes mellitus	0.000228	0.0013	CcSEcCtD
Indacaterol—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000227	0.00129	CcSEcCtD
Indacaterol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000226	0.00129	CcSEcCtD
Indacaterol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000226	0.00129	CcSEcCtD
Indacaterol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000226	0.00129	CcSEcCtD
Indacaterol—Palpitations—Losartan—type 2 diabetes mellitus	0.000225	0.00129	CcSEcCtD
Indacaterol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000225	0.00128	CcSEcCtD
Indacaterol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000224	0.00128	CcSEcCtD
Indacaterol—Cough—Losartan—type 2 diabetes mellitus	0.000223	0.00127	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000222	0.00127	CcSEcCtD
Indacaterol—Pruritus—Glyburide—type 2 diabetes mellitus	0.000221	0.00126	CcSEcCtD
Indacaterol—Infection—Irbesartan—type 2 diabetes mellitus	0.00022	0.00125	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00022	0.00125	CcSEcCtD
Indacaterol—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000219	0.00125	CcSEcCtD
Indacaterol—Myalgia—Losartan—type 2 diabetes mellitus	0.000217	0.00124	CcSEcCtD
Indacaterol—Chest pain—Losartan—type 2 diabetes mellitus	0.000217	0.00124	CcSEcCtD
Indacaterol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000217	0.00124	CcSEcCtD
Indacaterol—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000216	0.00123	CcSEcCtD
Indacaterol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00123	CcSEcCtD
Indacaterol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00123	CcSEcCtD
Indacaterol—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000215	0.00123	CcSEcCtD
Indacaterol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00122	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000214	0.00122	CcSEcCtD
Indacaterol—Dry mouth—Losartan—type 2 diabetes mellitus	0.000212	0.00121	CcSEcCtD
Indacaterol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00021	0.0012	CcSEcCtD
Indacaterol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00021	0.0012	CcSEcCtD
Indacaterol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000209	0.00119	CcSEcCtD
Indacaterol—Infection—Losartan—type 2 diabetes mellitus	0.000207	0.00118	CcSEcCtD
Indacaterol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000206	0.00118	CcSEcCtD
Indacaterol—Tremor—Ramipril—type 2 diabetes mellitus	0.000205	0.00117	CcSEcCtD
Indacaterol—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000204	0.00116	CcSEcCtD
Indacaterol—Tachycardia—Losartan—type 2 diabetes mellitus	0.000203	0.00116	CcSEcCtD
Indacaterol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00116	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000202	0.00115	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000201	0.00115	CcSEcCtD
Indacaterol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000199	0.00113	CcSEcCtD
Indacaterol—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000198	0.00113	CcSEcCtD
Indacaterol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000197	0.00112	CcSEcCtD
Indacaterol—Rash—Glyburide—type 2 diabetes mellitus	0.000197	0.00112	CcSEcCtD
Indacaterol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000197	0.00112	CcSEcCtD
Indacaterol—Vertigo—Ramipril—type 2 diabetes mellitus	0.000196	0.00112	CcSEcCtD
Indacaterol—Headache—Glyburide—type 2 diabetes mellitus	0.000195	0.00111	CcSEcCtD
Indacaterol—Palpitations—Ramipril—type 2 diabetes mellitus	0.000193	0.0011	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000191	0.00109	CcSEcCtD
Indacaterol—Cough—Ramipril—type 2 diabetes mellitus	0.000191	0.00109	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00019	0.00108	CcSEcCtD
Indacaterol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00019	0.00108	CcSEcCtD
Indacaterol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000187	0.00107	CcSEcCtD
Indacaterol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000187	0.00107	CcSEcCtD
Indacaterol—Chest pain—Ramipril—type 2 diabetes mellitus	0.000186	0.00106	CcSEcCtD
Indacaterol—Myalgia—Ramipril—type 2 diabetes mellitus	0.000186	0.00106	CcSEcCtD
Indacaterol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000186	0.00106	CcSEcCtD
Indacaterol—Nausea—Glyburide—type 2 diabetes mellitus	0.000185	0.00106	CcSEcCtD
Indacaterol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000185	0.00106	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000185	0.00105	CcSEcCtD
Indacaterol—Pruritus—Valsartan—type 2 diabetes mellitus	0.000182	0.00104	CcSEcCtD
Indacaterol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000182	0.00104	CcSEcCtD
Indacaterol—Pruritus—Orlistat—type 2 diabetes mellitus	0.00018	0.00103	CcSEcCtD
Indacaterol—Rash—Gliclazide—type 2 diabetes mellitus	0.000177	0.00101	CcSEcCtD
Indacaterol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000176	0.00101	CcSEcCtD
Indacaterol—Headache—Gliclazide—type 2 diabetes mellitus	0.000175	0.001	CcSEcCtD
Indacaterol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000175	0.000999	CcSEcCtD
Indacaterol—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000174	0.000994	CcSEcCtD
Indacaterol—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000173	0.000989	CcSEcCtD
Indacaterol—Dizziness—Valsartan—type 2 diabetes mellitus	0.00017	0.000971	CcSEcCtD
Indacaterol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000168	0.000959	CcSEcCtD
Indacaterol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000166	0.000949	CcSEcCtD
Indacaterol—Pruritus—Metformin—type 2 diabetes mellitus	0.000166	0.000946	CcSEcCtD
Indacaterol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000163	0.00093	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000163	0.000928	CcSEcCtD
Indacaterol—Rash—Valsartan—type 2 diabetes mellitus	0.000162	0.000926	CcSEcCtD
Indacaterol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000162	0.000925	CcSEcCtD
Indacaterol—Headache—Valsartan—type 2 diabetes mellitus	0.000161	0.00092	CcSEcCtD
Indacaterol—Rash—Orlistat—type 2 diabetes mellitus	0.00016	0.000915	CcSEcCtD
Indacaterol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00016	0.000914	CcSEcCtD
Indacaterol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00016	0.000914	CcSEcCtD
Indacaterol—Headache—Orlistat—type 2 diabetes mellitus	0.000159	0.000909	CcSEcCtD
Indacaterol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000159	0.000908	CcSEcCtD
Indacaterol—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000156	0.000893	CcSEcCtD
Indacaterol—Dizziness—Metformin—type 2 diabetes mellitus	0.000155	0.000884	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.000879	CcSEcCtD
Indacaterol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000153	0.000875	CcSEcCtD
Indacaterol—Nausea—Valsartan—type 2 diabetes mellitus	0.000153	0.000872	CcSEcCtD
Indacaterol—Nausea—Orlistat—type 2 diabetes mellitus	0.000151	0.000862	CcSEcCtD
Indacaterol—Rash—Metformin—type 2 diabetes mellitus	0.000148	0.000843	CcSEcCtD
Indacaterol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000148	0.000842	CcSEcCtD
Indacaterol—Pruritus—Losartan—type 2 diabetes mellitus	0.000147	0.00084	CcSEcCtD
Indacaterol—Headache—Metformin—type 2 diabetes mellitus	0.000147	0.000838	CcSEcCtD
Indacaterol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000146	0.000834	CcSEcCtD
Indacaterol—Rash—Irbesartan—type 2 diabetes mellitus	0.000139	0.000796	CcSEcCtD
Indacaterol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000139	0.000795	CcSEcCtD
Indacaterol—Nausea—Metformin—type 2 diabetes mellitus	0.000139	0.000794	CcSEcCtD
Indacaterol—Headache—Irbesartan—type 2 diabetes mellitus	0.000139	0.000791	CcSEcCtD
Indacaterol—Dizziness—Losartan—type 2 diabetes mellitus	0.000138	0.000785	CcSEcCtD
Indacaterol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000131	0.00075	CcSEcCtD
Indacaterol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000131	0.00075	CcSEcCtD
Indacaterol—Rash—Losartan—type 2 diabetes mellitus	0.000131	0.000749	CcSEcCtD
Indacaterol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000131	0.000748	CcSEcCtD
Indacaterol—Headache—Losartan—type 2 diabetes mellitus	0.00013	0.000744	CcSEcCtD
Indacaterol—Pruritus—Ramipril—type 2 diabetes mellitus	0.000126	0.00072	CcSEcCtD
Indacaterol—Nausea—Losartan—type 2 diabetes mellitus	0.000124	0.000705	CcSEcCtD
Indacaterol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000118	0.000673	CcSEcCtD
Indacaterol—Rash—Ramipril—type 2 diabetes mellitus	0.000113	0.000642	CcSEcCtD
Indacaterol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000112	0.000641	CcSEcCtD
Indacaterol—Headache—Ramipril—type 2 diabetes mellitus	0.000112	0.000638	CcSEcCtD
Indacaterol—Nausea—Ramipril—type 2 diabetes mellitus	0.000106	0.000605	CcSEcCtD
Indacaterol—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.34e-05	0.000173	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.34e-05	0.000173	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.34e-05	0.000173	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.33e-05	0.000172	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.33e-05	0.000172	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.32e-05	0.000171	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.32e-05	0.000171	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.32e-05	0.000171	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.32e-05	0.000171	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.31e-05	0.00017	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.31e-05	0.000169	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.3e-05	0.000168	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.3e-05	0.000168	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.3e-05	0.000168	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.28e-05	0.000166	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.28e-05	0.000165	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.27e-05	0.000165	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.27e-05	0.000164	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.25e-05	0.000161	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.24e-05	0.000161	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.24e-05	0.00016	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.22e-05	0.000158	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.22e-05	0.000158	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.22e-05	0.000158	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.21e-05	0.000157	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AGT—type 2 diabetes mellitus	1.21e-05	0.000156	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.19e-05	0.000155	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.19e-05	0.000154	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.19e-05	0.000154	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.19e-05	0.000154	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOE—type 2 diabetes mellitus	1.18e-05	0.000153	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.17e-05	0.000151	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.17e-05	0.000151	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.17e-05	0.000151	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.15e-05	0.000149	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.15e-05	0.000148	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.14e-05	0.000148	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.14e-05	0.000147	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.13e-05	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.13e-05	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.13e-05	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.12e-05	0.000145	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.12e-05	0.000145	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.12e-05	0.000145	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.11e-05	0.000144	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.11e-05	0.000143	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.1e-05	0.000143	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.1e-05	0.000143	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.1e-05	0.000142	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.09e-05	0.000142	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.09e-05	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.08e-05	0.00014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.07e-05	0.000139	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.07e-05	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.07e-05	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.06e-05	0.000138	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.06e-05	0.000137	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.06e-05	0.000137	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.06e-05	0.000137	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.05e-05	0.000136	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.05e-05	0.000136	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.04e-05	0.000135	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.04e-05	0.000135	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.04e-05	0.000135	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.04e-05	0.000134	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.03e-05	0.000133	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.02e-05	0.000133	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000132	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.02e-05	0.000132	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	1.01e-05	0.000131	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1e-05	0.00013	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1e-05	0.00013	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1e-05	0.00013	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.97e-06	0.000129	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.84e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.77e-06	0.000126	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.68e-06	0.000125	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.68e-06	0.000125	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.68e-06	0.000125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.59e-06	0.000124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.56e-06	0.000124	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.52e-06	0.000123	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.52e-06	0.000123	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.52e-06	0.000123	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.39e-06	0.000121	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	9.38e-06	0.000121	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.34e-06	0.000121	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	9.26e-06	0.00012	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.26e-06	0.00012	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	9.17e-06	0.000119	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.1e-06	0.000118	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.07e-06	0.000117	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.06e-06	0.000117	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.94e-06	0.000116	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.92e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.91e-06	0.000115	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	8.86e-06	0.000115	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.86e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.76e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.75e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.73e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.73e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.73e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	8.71e-06	0.000113	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.7e-06	0.000113	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.63e-06	0.000112	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.61e-06	0.000111	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.61e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.57e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	8.54e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	8.54e-06	0.000111	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.52e-06	0.00011	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.44e-06	0.000109	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.39e-06	0.000109	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.25e-06	0.000107	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.25e-06	0.000107	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.23e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.23e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.23e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.23e-06	0.000107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.23e-06	0.000107	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	8.11e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.05e-06	0.000104	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.89e-06	0.000102	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.79e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.62e-06	9.86e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	7.46e-06	9.65e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.34e-06	9.5e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.33e-06	9.49e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	7.29e-06	9.44e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.21e-06	9.34e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.21e-06	9.33e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.18e-06	9.29e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.18e-06	9.29e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.11e-06	9.21e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.11e-06	9.21e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.08e-06	9.16e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.06e-06	9.13e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.05e-06	9.13e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.02e-06	9.09e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.98e-06	9.04e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.85e-06	8.87e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.85e-06	8.86e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.78e-06	8.78e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.71e-06	8.68e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.71e-06	8.68e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.7e-06	8.67e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.6e-06	8.54e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.58e-06	8.52e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.54e-06	8.47e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.54e-06	8.47e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.54e-06	8.46e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.54e-06	8.46e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.54e-06	8.46e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.5e-06	8.41e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.47e-06	8.38e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.4e-06	8.28e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.4e-06	8.28e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.38e-06	8.26e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.34e-06	8.21e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.32e-06	8.18e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.31e-06	8.16e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.16e-06	7.97e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.15e-06	7.96e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.07e-06	7.86e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.02e-06	7.79e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.86e-06	7.59e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.86e-06	7.59e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.86e-06	7.59e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.83e-06	7.55e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.75e-06	7.45e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.72e-06	7.4e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.7e-06	7.38e-05	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.6e-06	7.25e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.58e-06	7.23e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.55e-06	7.19e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.54e-06	7.17e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.52e-06	7.14e-05	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.48e-06	7.1e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.45e-06	7.05e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.43e-06	7.03e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.43e-06	7.03e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.4e-06	6.99e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.36e-06	6.94e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.36e-06	6.94e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.3e-06	6.86e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.3e-06	6.86e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.25e-06	6.79e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.19e-06	6.72e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.13e-06	6.64e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.09e-06	6.59e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.08e-06	6.58e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.08e-06	6.58e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.08e-06	6.57e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.98e-06	6.44e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.84e-06	6.26e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.73e-06	6.13e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.73e-06	6.12e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.71e-06	6.1e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.64e-06	6e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.61e-06	5.97e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.38e-06	5.67e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.38e-06	5.67e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.36e-06	5.65e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.32e-06	5.6e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.3e-06	5.57e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.25e-06	5.5e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.24e-06	5.49e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.23e-06	5.48e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.18e-06	5.41e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.15e-06	5.37e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	4.07e-06	5.27e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.07e-06	5.26e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.07e-06	5.26e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.06e-06	5.26e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.99e-06	5.16e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.9e-06	5.06e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.89e-06	5.04e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.79e-06	4.91e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.74e-06	4.84e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.72e-06	4.81e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.59e-06	4.65e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.52e-06	4.56e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.41e-06	4.42e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.36e-06	4.34e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.34e-06	4.33e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.31e-06	4.28e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.26e-06	4.22e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-06	4.13e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.01e-06	3.89e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.94e-06	3.81e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.91e-06	3.77e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.86e-06	3.7e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.62e-06	3.39e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.5e-06	3.24e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.5e-06	3.24e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.29e-06	2.97e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.87e-06	2.42e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.15e-06	1.49e-05	CbGpPWpGaD
